SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Petrini B)
 

Search: WFRF:(Petrini B) > Third Åland islands...

Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Berntorp, Erik (author)
Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups
Fuchs, B (author)
Makris, M (author)
show more...
Montgomery, R (author)
Flood, V (author)
O'Donnell, J S (author)
Federici, A B (author)
Lillicrap, D (author)
James, Peter (author)
Lund University,Lunds universitet,Institutionen för immunteknologi,Institutioner vid LTH,Lunds Tekniska Högskola,Department of Immunotechnology,Departments at LTH,Faculty of Engineering, LTH
Budde, U (author)
Morfini, M (author)
Petrini, Alexander (author)
Lund University,Lunds universitet,Människan i rörelse: hälsa och rehabilitering,Forskargrupper vid Lunds universitet,Human Movement: health and rehabilitation,Lund University Research Groups
Austin, S (author)
Kannicht, C (author)
Jiménez-Yuste, V (author)
Lee, C (author)
show less...
 (creator_code:org_t)
2013-02-06
2013
English.
In: Haemophilia. - : Wiley. - 1351-8216. ; 19 Suppl 3, s. 1-18
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The first meeting of international specialists in the field of von Willebrand disease (VWD) was held in the Åland islands in 1998 where Erik von Willebrand had first observed a bleeding disorder in some members of a family from Föglö and a summary of the meeting was published in 1999. The second meeting was held in 2010 and a report of the meeting was published in 2012. Topics covered included progress in understanding of VWD over the last 50 years; multimers; classification of VWD; pharmacokinetics and laboratory assays; genetics; treating the paediatric patient; prophylaxis; geriatrics; gene therapy and treatment guidelines. This third meeting held over 3 days covered the structure and function of von Willebrand factor (VWF); type 1 VWD, the most common form of the disease; a lifespan of pharmacokinetics in VWD; detecting inhibitors in VWD patients; and special challenges in understanding and treating the female VWD patient.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view